Valneva SE (VALN) Gross Margin (2021 - 2026)
Valneva SE (VALN) posted Gross Margin of 15.29% for Q1 2026, up 142.29% sequentially from 6.31% in Q4 2025, and down 3791.0% YoY from 0.41% in Q1 2025.
Powered by 
Analysis
Valneva SE (VALN) Gross Margin (2021 - 2026) Analysis & Trends
Valneva SE has reported Gross Margin for 6 years, with the latest figure at 15.29% in Q1 2026.
- Quarterly Gross Margin fell 3791.0% year-over-year to 15.29% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.68% (down 2393.0% YoY) and the FY2025 annual result came in at 32.15%, down 751.0% from the prior year.
- Gross Margin improved to 15.29% in Q1 2026 per VALN's latest filing, from 6.31% in the prior quarter.
- Over five years, Gross Margin peaked at 80.06% in Q3 2022 and troughed at 120.83% in Q2 2022.
- A 5-year average of 23.3% and a median of 37.79% in 2023 frame the typical range for Gross Margin.
- The widest YoY moves for Gross Margin: up 53861 bps in 2022, down 13795 bps in 2022.
- Over 5 years, Gross Margin stood at 9.26% in 2022, then soared by 508 bps to 37.79% in 2023, then advanced by 23 bps to 46.39% in 2024, then slumped by 86 bps to 6.31% in 2025, then jumped by 142 bps to 15.29% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 15.29%, 6.31%, and 9.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 84.20% |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn | 4.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.58% |
| Mar 31, 2026 | 15.29% |
| Dec 31, 2025 | 24.36% |
| Sep 30, 2025 | 18.71% |
| Jun 30, 2025 | 50.10% |
| Mar 31, 2025 | 53.20% |
| Dec 31, 2024 | 48.56% |
| Sep 30, 2024 | 43.96% |
| Jun 30, 2024 | 38.34% |
| Mar 31, 2024 | 32.34% |
| Dec 31, 2023 | 37.79% |
| Sep 30, 2023 | 44.91% |
| Jun 30, 2023 | 17.09% |
| Mar 31, 2023 | 38.88% |
| Dec 31, 2022 | -9.26% |
| Sep 30, 2022 | 80.06% |
| Jun 30, 2022 | -120.83% |
| Mar 31, 2022 | 36.56% |
| Dec 31, 2021 | 89.82% |
| Sep 30, 2021 | -458.55% |